Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;83:516-522

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, L.
Right arrow Articles by Wang, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.
Right arrow Articles by Wang, P. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOXORUBICIN
(Circulation Research. 1998;83:516-522.)
© 1998 American Heart Association, Inc.


Original Contributions

Regulation of Cardiomyocyte Apoptotic Signaling by Insulin-like Growth Factor I

Lei Wang, Weiqiong Ma, Rachelle Markovich, Jaw-Wen Chen, , Ping H. Wang

From the Departments of Medicine and Biological Chemistry, Division of Endocrinology, Diabetes, and Metabolism, University of California, Irvine.

Correspondence to Ping H. Wang, MD, University of California, Department of Medicine, Medical Science I, Room C240, Irvine, CA 92697-4086.

Abstract—Apoptosis is regulated by specific intracellular signaling pathways. The development of cardiomyopathy involves the apoptosis of cardiomyocytes; however, the details of their apoptotic signaling are not yet known. Insulin-like growth factor I (IGF I) is an important survival growth factor for myocardium and other tissues, but the effects of IGF I on apoptotic signaling remain largely unknown. To study apoptotic signaling pathways in cardiomyocytes and to understand IGF I actions on the apoptotic signaling of cardiac muscle cells, we have defined the effects of IGF I on Bcl-2, Bax, caspase 3, DNA fragmentation, and cell survival in primary cardiomyocytes. Compared with Bax levels, the levels of Bcl-2 were found to be quite low in these cells. Serum withdrawal and doxorubicin reduced cell viability, increased fragmentation of DNA, increased cellular contents of Bax, and activated caspase 3. IGF I enhanced cell viability, suppressed DNA fragmentation, attenuated Bax induction, and suppressed caspase 3 activation. The levels of Bcl-2–associated Bax were increased after serum withdrawal and incubation with doxorubicin and were reduced by IGF I. Thus, cardiomyocyte apoptosis induced by serum withdrawal and doxorubicin likely results, in part, from the induction of Bax and activation of caspase 3, but IGF I may inhibit cardiomyocyte apoptosis by attenuating Bax induction and caspase 3 activation. These findings provide new insight into the mechanisms of cardiomyocytes apoptosis and may help elucidate how IGF I modulates apoptotic signaling in cardiac muscle.


Key Words: apoptosis • insulin-like growth factor I • cardiac muscle • caspase 3 • Bax




This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Honsho, S. Nishikawa, K. Amano, K. Zen, Y. Adachi, E. Kishita, A. Matsui, A. Katsume, S. Yamaguchi, K. Nishikawa, et al.
Pressure-Mediated Hypertrophy and Mechanical Stretch Induces IL-1 Release and Subsequent IGF-1 Generation to Maintain Compensative Hypertrophy by Affecting Akt and JNK Pathways
Circ. Res., November 20, 2009; 105(11): 1149 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J. Hausenloy and D. M. Yellon
Cardioprotective growth factors
Cardiovasc Res, July 15, 2009; 83(2): 179 - 194.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
X. Shen, G. Xi, Y. Radhakrishnan, and D. R. Clemmons
Identification of Novel SHPS-1-associated Proteins and Their Roles in Regulation of Insulin-like Growth Factor-dependent Responses in Vascular Smooth Muscle Cells
Mol. Cell. Proteomics, July 1, 2009; 8(7): 1539 - 1551.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S.-J. Kim, M. Abdellatif, S. Koul, and G. J. Crystal
Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H130 - H135.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Skurk, F. Wittchen, L. Suckau, H. Witt, M. Noutsias, H. Fechner, H.-P. Schultheiss, and W. Poller
Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy
Eur. Heart J., May 1, 2008; 29(9): 1168 - 1180.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. S. Hu, L. K. Landeen, N. Aroonsakool, and W. R. Giles
An analysis of the effects of stretch on IGF-I secretion from rat ventricular fibroblasts
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H677 - H683.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
W. Ibe, A. Saraste, S. Lindemann, S. Bruder, M. Buerke, H. Darius, K. Pulkki, and L.-M. Voipio-Pulkki
Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment
Eur J Heart Fail, February 1, 2007; 9(2): 160 - 167.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
T.-J. Liu, H.-C. Lai, C.-T. Ting, and P. H Wang
Bidirectional regulation of upstream IGF-I/insulin receptor signaling and downstream FOXO1 in cardiomyocytes
J. Endocrinol., January 1, 2007; 192(1): 149 - 158.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
I. Shiojima and K. Walsh
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
Genes & Dev., December 15, 2006; 20(24): 3347 - 3365.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Gude, J. Muraski, M. Rubio, J. Kajstura, E. Schaefer, P. Anversa, and M. A. Sussman
Akt Promotes Increased Cardiomyocyte Cycling and Expansion of the Cardiac Progenitor Cell Population
Circ. Res., August 18, 2006; 99(4): 381 - 388.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. C. Chua, X. Liu, J. Gao, R. C. Hamdy, and B. H. L. Chua
Multiple actions of pifithrin-{alpha} on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2606 - H2613.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Li, R. Y. T. Sung, W. Z. Huang, M. Yang, N. H. Pong, S. M. Lee, W. Y. Chan, H. Zhao, M. Y. To, T. F. Fok, et al.
Thrombopoietin Protects Against In Vitro and In Vivo Cardiotoxicity Induced by Doxorubicin
Circulation, May 9, 2006; 113(18): 2211 - 2220.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H.-F. Su, A. Samsamshariat, J. Fu, Y.-X. Shan, Y.-H. Chen, D. Piomelli, and P. H. Wang
Oleylethanolamide Activates Ras-Erk Pathway and Improves Myocardial Function in Doxorubicin-Induced Heart Failure
Endocrinology, February 1, 2006; 147(2): 827 - 834.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Marleau, M. Mulumba, D. Lamontagne, and H. Ong
Cardiac and peripheral actions of growth hormone and its releasing peptides: Relevance for the treatment of cardiomyopathies
Cardiovasc Res, January 1, 2006; 69(1): 26 - 35.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. P.M. van Empel, A. T.A. Bertrand, L. Hofstra, H. J. Crijns, P. A. Doevendans, and L. J. De Windt
Myocyte apoptosis in heart failure
Cardiovasc Res, July 1, 2005; 67(1): 21 - 29.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Kofidis, J. L. de Bruin, T. Yamane, M. Tanaka, D. R. Lebl, R.-J. Swijnenburg, I. L. Weissman, and R. C. Robbins
Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Injury
Circulation, May 17, 2005; 111(19): 2486 - 2493.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Tanaka, S. Nakae, R. D. Terry, G. K. Mokhtari, F. Gunawan, L. B. Balsam, H. Kaneda, T. Kofidis, P. S. Tsao, and R. C. Robbins
Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease
Blood, December 1, 2004; 104(12): 3789 - 3796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. M. Jang, L. E.-C. Leong, L. T. Hoang, P. H. Wang, G. A. Gutman, and B. L. Semler
Structurally Distinct Elements Mediate Internal Ribosome Entry within the 5'-Noncoding Region of a Voltage-gated Potassium Channel mRNA
J. Biol. Chem., November 12, 2004; 279(46): 47419 - 47430.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. T. Crow, K. Mani, Y.-J. Nam, and R. N. Kitsis
The Mitochondrial Death Pathway and Cardiac Myocyte Apoptosis
Circ. Res., November 12, 2004; 95(10): 957 - 970.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. P.M van Empel and L. J De Windt
Myocyte hypertrophy and apoptosis: a balancing act
Cardiovasc Res, August 15, 2004; 63(3): 487 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Wang, E. A. Konorev, S. Kotamraju, J. Joseph, S. Kalivendi, and B. Kalyanaraman
Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms: INTERMEDIACY OF H2O2- AND p53-DEPENDENT PATHWAYS
J. Biol. Chem., June 11, 2004; 279(24): 25535 - 25543.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
Pharmacol. Rev., June 1, 2004; 56(2): 185 - 229.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Tokudome, T. Horio, M. Fukunaga, H. Okumura, J. Hino, K. Mori, F. Yoshihara, S.-I. Suga, Y. Kawano, M. Kohno, et al.
Ventricular Nonmyocytes Inhibit Doxorubicin-Induced Myocyte Apoptosis: Involvement of Endogenous Endothelin-1 as a Paracrine Factor
Endocrinology, May 1, 2004; 145(5): 2458 - 2466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-J. Pang, R.-K. Xu, X.-B. Xu, J.-M. Cao, C. Ni, W.-L. Zhu, K. Asotra, M.-C. Chen, and C. Chen
Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1063 - H1069.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J Hausenloy and D. M Yellon
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
Cardiovasc Res, February 15, 2004; 61(3): 448 - 460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. P. Aoki, N. L. Guinazu, A. V. Pellegrini, T. Gotoh, D. T. Masih, and S. Gea
Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes
Am J Physiol Cell Physiol, February 1, 2004; 286(2): C206 - C212.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
R. S. Vasan, L. M. Sullivan, R. B. D'Agostino, R. Roubenoff, T. Harris, D. B. Sawyer, D. Levy, and P. W.F. Wilson
Serum Insulin-like Growth Factor I and Risk for Heart Failure in Elderly Individuals without a Previous Myocardial Infarction: The Framingham Heart Study
Ann Intern Med, October 21, 2003; 139(8): 642 - 648.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Gonzalez, M. A Fortuno, R. Querejeta, S. Ravassa, B. Lopez, N. Lopez, and J. Diez
Cardiomyocyte apoptosis in hypertensive cardiomyopathy
Cardiovasc Res, September 1, 2003; 59(3): 549 - 562.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. J. Su, C. L. Cioffi, S. Stefansson, N. Mittereder, M. Garay, D. Hreniuk, and G. Liau
Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization
Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1429 - H1440.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Yamanaka, T. Tatsumi, J. Shiraishi, A. Mano, N. Keira, S. Matoba, J. Asayama, S. Fushiki, H. Fliss, and M. Nakagawa
Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes
J. Am. Coll. Cardiol., March 5, 2003; 41(5): 870 - 878.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. von Lewinski, K. Voss, S. Hulsmann, H. Kogler, and B. Pieske
Insulin-Like Growth Factor-1 Exerts Ca2+-Dependent Positive Inotropic Effects in Failing Human Myocardium
Circ. Res., February 7, 2003; 92(2): 169 - 176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Duan, H.-Y. Zhang, S. D. Adkins, B. H. Ren, F. L. Norby, X. Zhang, J. N. Benoit, P. N. Epstein, and J. Ren
Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E366 - E376.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Tokudome, T. Horio, F. Yoshihara, S.-i. Suga, Y. Kawano, M. Kohno, and K. Kangawa
Adrenomedullin Inhibits Doxorubicin-Induced Cultured Rat Cardiac Myocyte Apoptosis via a cAMP-Dependent Mechanism
Endocrinology, September 1, 2002; 143(9): 3515 - 3521.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Chao, Y. Shen, L. Li, and A. Rosenzweig
Importance of FADD Signaling in Serum Deprivation- and Hypoxia-induced Cardiomyocyte Apoptosis
J. Biol. Chem., August 23, 2002; 277(35): 31639 - 31645.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. R. Wilkins, K. Ohneda, T. O. Keku, A. J. D'Ercole, C. R. Fuller, K. L. Williams, and P. K. Lund
Reduction of spontaneous and irradiation-induced apoptosis in small intestine of IGF-I transgenic mice
Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G457 - G464.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. GILL, R. MESTRIL, and A. SAMALI
Losing heart: the role of apoptosis in heart disease--a novel therapeutic target?
FASEB J, February 1, 2002; 16(2): 135 - 146.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Shiraishi, T. Tatsumi, N. Keira, K. Akashi, A. Mano, S. Yamanaka, S. Matoba, J. Asayama, T. Yaoi, S. Fushiki, et al.
Important role of energy-dependent mitochondrial pathways in cultured rat cardiac myocyte apoptosis
Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1637 - H1647.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Nakao, H. Otani, T. Yamamura, R. Hattori, M. Osako, and H. Imamura
Insulin-like growth factor 1 prevents neuronal cell death and paraplegia in the rabbit model of spinal cord ischemia
J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 136 - 143.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Beery, M. Haimsohn, N. Wertheim, R. Hemi, U. Nir, A. Karasik, H. Kanety, and A. Geier
Activation of the Insulin-Like Growth Factor 1 Signaling Pathway by the Antiapoptotic Agents Aurintricarboxylic Acid and Evans Blue
Endocrinology, July 1, 2001; 142(7): 3098 - 3107.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Palmen, M.J.A.P. Daemen, R. Bronsaer, W.R.M. Dassen, H.R. Zandbergen, M. Kockx, J.F.M. Smits, R. van der Zee, and P.A. Doevendans
Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice
Cardiovasc Res, June 1, 2001; 50(3): 516 - 524.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Kakinuma, T. Miyauchi, K. Yuki, N. Murakoshi, K. Goto, and I. Yamaguchi
Novel Molecular Mechanism of Increased Myocardial Endothelin-1 Expression in the Failing Heart Involving the Transcriptional Factor Hypoxia-Inducible Factor-1{{alpha}} Induced for Impaired Myocardial Energy Metabolism
Circulation, May 15, 2001; 103(19): 2387 - 2394.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Yamashita, J. Kajstura, D. J. Discher, B. J. Wasserlauf, N. H. Bishopric, P. Anversa, and K. A. Webster
Reperfusion-Activated Akt Kinase Prevents Apoptosis in Transgenic Mouse Hearts Overexpressing Insulin-Like Growth Factor-1
Circ. Res., March 30, 2001; 88(6): 609 - 614.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Adachi, H. Ito, M. Tamamori-Adachi, Y. Ono, T. Nozato, S. Abe, M.-a. Ikeda, F. Marumo, and M. Hiroe
Cyclin A/cdk2 Activation Is Involved in Hypoxia-Induced Apoptosis in Cardiomyocytes
Circ. Res., March 2, 2001; 88(4): 408 - 414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Yamamura, H. Otani, Y. Nakao, R. Hattori, M. Osako, and H. Imamura
IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1191 - H1200.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Negoro, H. Oh, E. Tone, K. Kunisada, Y. Fujio, K. Walsh, T. Kishimoto, and K. Yamauchi-Takihara
Glycoprotein 130 Regulates Cardiac Myocyte Survival in Doxorubicin-Induced Apoptosis Through Phosphatidylinositol 3-Kinase/Akt Phosphorylation and Bcl-xL/Caspase-3 Interaction
Circulation, January 30, 2001; 103(4): 555 - 561.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Wen, J. Gu, Y. Liu, P. H. Wang, Y. Sun, and J. L. Nadler
Overexpression of 12-Lipoxygenase Causes Cardiac Fibroblast Cell Growth
Circ. Res., January 19, 2001; 88(1): 70 - 76.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Aikawa, M. Nawano, Y. Gu, H. Katagiri, T. Asano, W. Zhu, R. Nagai, and I. Komuro
Insulin Prevents Cardiomyocytes From Oxidative Stress-Induced Apoptosis Through Activation of PI3 Kinase/Akt
Circulation, December 5, 2000; 102(23): 2873 - 2879.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. He, Y. Xiao, C. A. Casiano, and L. Zhang
Role of Mitochondrial Cytochrome c in Cocaine-Induced Apoptosis in Coronary Artery Endothelial Cells
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 896 - 903.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. E. McDonald, M. N. Grinman, C. M. Carthy, and K. R. Walley
Endotoxin infusion in rats induces apoptotic and survival pathways in hearts
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2053 - H2061.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C Berry and A.L Clark
Catabolism in chronic heart failure
Eur. Heart J., April 1, 2000; 21(7): 521 - 532.
[PDF]


Home page
Circ. Res.Home page
A. Haunstetter and S. Izumo
Toward Antiapoptosis as a New Treatment Modality
Circ. Res., March 3, 2000; 86(4): 371 - 376.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Adderley and D. J. Fitzgerald
Glycoprotein IIb/IIIa Antagonists Induce Apoptosis in Rat Cardiomyocytes by Caspase-3 Activation
J. Biol. Chem., February 25, 2000; 275(8): 5760 - 5766.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. J. De Windt, H. W. Lim, T. Taigen, D. Wencker, G. Condorelli, G. W. Dorn II, R. N. Kitsis, and J. D. Molkentin
Calcineurin-Mediated Hypertrophy Protects Cardiomyocytes From Apoptosis In Vitro and In Vivo : An Apoptosis-Independent Model of Dilated Heart Failure
Circ. Res., February 18, 2000; 86(3): 255 - 263.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Fujio, T. Nguyen, D. Wencker, R. N. Kitsis, and K. Walsh
Akt Promotes Survival of Cardiomyocytes In Vitro and Protects Against Ischemia-Reperfusion Injury in Mouse Heart
Circulation, February 15, 2000; 101(6): 660 - 667.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Z. Feuerstein and P. R. Young
Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways
Cardiovasc Res, February 1, 2000; 45(3): 560 - 569.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Yaoita, K. Ogawa, K. Maehara, and Y. Maruyama
Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction
Cardiovasc Res, February 1, 2000; 45(3): 630 - 641.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Haunstetter and S. Izumo
Future perspectives and potential implications of cardiac myocyte apoptosis
Cardiovasc Res, February 1, 2000; 45(3): 795 - 801.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Xiao, J. He, R. D. Gilbert, and L. Zhang
Cocaine Induces Apoptosis in Fetal Myocardial Cells through a Mitochondria-Dependent Pathway
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 8 - 14.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Matsui, L. Li, F. del Monte, Y. Fukui, T. F. Franke, R. J. Hajjar, and A. Rosenzweig
Adenoviral Gene Transfer of Activated Phosphatidylinositol 3'-Kinase and Akt Inhibits Apoptosis of Hypoxic Cardiomyocytes In Vitro
Circulation, December 7, 1999; 100(23): 2373 - 2379.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. C. DELAUGHTER, G. E. TAFFET, M. L. FIOROTTO, M. L. ENTMAN, and R. J. SCHWARTZ
Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice
FASEB J, November 1, 1999; 13(14): 1923 - 1929.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Brink, J. Chrast, S. R. Price, W. E. Mitch, and P. Delafontaine
Angiotensin II Stimulates Gene Expression of Cardiac Insulin-Like Growth Factor I and Its Receptor Through Effects on Blood Pressure and Food Intake
Hypertension, November 1, 1999; 34(5): 1053 - 1059.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W.-L. Lee, J.-W. Chen, C.-T. Ting, T. Ishiwata, S.-J. Lin, M. Korc, and P. H. Wang
Insulin-Like Growth Factor I Improves Cardiovascular Function and Suppresses Apoptosis of Cardiomyocytes in Dilated Cardiomyopathy
Endocrinology, October 1, 1999; 140(10): 4831 - 4840.
[Abstract] [Full Text]


Home page
FASEB J.Home page
N. ANDRIEU-ABADIE, J.-P. JAFFRÉZOU, S. HATEM, G. LAURENT, T. LEVADE, and J.-J. MERCADIER
L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation
FASEB J, September 1, 1999; 13(12): 1501 - 1510.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
E. Delpy, S. N Hatem, N. Andrieu, C. de Vaumas, M. Henaff, C. Rucker-Martin, J.-P. Jaffrezou, G. Laurent, T. Levade, and J.-J. Mercadier
Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes
Cardiovasc Res, August 1, 1999; 43(2): 398 - 407.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. von Harsdorf, L. Hauck, F. Mehrhof, U. Wegenka, M. C. Cardoso, and R. Dietz
E2F-1 Overexpression in Cardiomyocytes Induces Downregulation of p21CIP1 and p27KIP1 and Release of Active Cyclin-Dependent Kinases in the Presence of Insulin-Like Growth Factor I
Circ. Res., July 23, 1999; 85(2): 128 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wu, W.-L. Lee, Y. Y. Wu, D. Chen, T.-J. Liu, A. Jang, P. M. Sharma, and P. H. Wang
Expression of Constitutively Active Phosphatidylinositol 3-Kinase Inhibits Activation of Caspase 3 and Apoptosis of Cardiac Muscle Cells
J. Biol. Chem., December 15, 2000; 275(51): 40113 - 40119.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Camper-Kirby, S. Welch, A. Walker, I. Shiraishi, K. D. R. Setchell, E. Schaefer, J. Kajstura, P. Anversa, and M. A. Sussman
Myocardial Akt Activation and Gender : Increased Nuclear Activity in Females Versus Males
Circ. Res., May 25, 2001; 88(10): 1020 - 1027.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T.-j. Liu, H.-c. Lai, W. Wu, S. Chinn, and P. H. Wang
Developing a Strategy to Define the Effects of Insulin-Like Growth Factor-1 on Gene Expression Profile in Cardiomyocytes
Circ. Res., June 22, 2001; 88(12): 1231 - 1238.
[Abstract] [Full Text] [PDF]